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increasing antimicrobial resistance it IS remarkable that, except in P 
aerugirrora, no significant change in resistance is readily detected in 
these two nationwide prevalence studies in The Netherlands. 
lp8571 Present situation of resistance of respiratory 
tract pathogens 
E. Cercenado, E Garcia-Garrote, K. San Juan, S. Hernangbmez, J. 
Martin-Pedroviejo, E. Bouza. Hospital Grqorio Marandn, Madrid, 
Spaiii 
Objectives: To determine the resistance of recent respiratory isolates 
(1 997-98) of S. pnelrmoniae (Sp), If. i?lpuenzae (Hi), M .  catarrlialis 
(Mc), S. pyofenes (SA) and Streptococcus group C (SC) to antimicro- 
bials and to compare resistance patterns with those of 1996 isolates. 
Materials and methods: Susceptibility to penicillin (PEN), 
ampicillin (AMP), amoxycillin-clavulanate (AMC), cefotaxime 
(CTX), erythromycin (ERY) and co-trimoxazole (SXT) was deter- 
mined by the broth microdilution method (NCCLS). Beta-lactamase 
production was detected by thmt nitrocefin test. 
Results: Percentages of resistance (NCCLS breakpoints) are 
shown in the table: 
Y m  PEN 
sp 9 6 8  2: 
Hi 96 - 
97-98 - 
Mc 96 - 
97-98 - 


































. _I . -.
sc 96 0 0 8 - - - 
8 0 0 1 4  _ _ _  
In 1996, among non-susceptible Sp, 22% were intermediate (I) 
and 36‘31 resistant (R), whereas in 1997-98 there were 21% I and 39% 
R. MICs of CTX were 3 2  &mL against 7% of 1997-98 isolates. 
N o  resistance to CTX and to quinolones was found among Hi and 
Mc. 73% of Dryer SA isolates presented the M phenotype, whereas 
only 0.5 of EKY-R Sp presented this phenotype. 
Conclusions: Resistance to PEN, CTX and EKY continues to 
increase among Sp, as well as the incidence of beta-lactaniase-produc- 
ing Hi and ERY-R SA and SC. 
/p8581 Is there emergence of resistance to cefepime 
after 24+ months of use? 
C.H. Ramirez-Ronda, C.Raniirez-Kdmirez, D. Vera. SanJnnti 
VAMC, Department of Infectious Diseases, School of Medicine, University 
o f i i i ~ ~ r r o  Rim, SariJ~ian, Puerro Rim 
Objectives: To compare the in vitro activity ofcefepime during two 
periods, 1991-95 and 1996-98 (cefepime use period), against aero- 
bic Gram-negative bacilli recovered from serious infections in hospi- 
talized patients. 
Methods: A total of 50 strains each per year of Klebsiella pnenmo- 
niae (KP), Klebsielln oxytora (KO), Erirerobacter cloacae (EC), Citrobacter 
jienndii (FC). Psrndomorias aevtigiwosa (PA), Psendomortas maltophilia 
Pre Use 1% Susceptibility1 Post Use 
1991 1992 1993 1994 1995 1996 1997 1998 
CEF 100 100 100 100 100 100 90 100 
CTZ 56 54 52 52 52 52 54 52 
CEF 96 94 96 98 100 98 97 100 
CTZ 58 60 56 52 52 52 54 53 
Conclusions: The susceptibilities of Ktehsiriia and Entero lac~r  did 
not change over the two study perlods. The susceptibilities ofP acrq -  
inosa to cefepime remained unchanged during the first study period 
and were comparable to that of ceftazidime; during the CEF use 
period, PA susceptibility decreased by 20%). 
KP 1101981 
EC 
lp859) Resistance of ceftazidime in a Hungarian 
hospital 
11. Szabo, C. Jeney, K. Glatz, Z .  Csukas, Z. Llerek, K.  Kamotsay, F. 
Rozgonyi. Institute (f Microbiolo~qy, Semriieliveis University .f Medicine, 
Bitdupest, Huripzry 
Objectives: The resistances of strains of Esrlwririiia coli, Klcbsielln and 
Eizt~r~hacter species to a panel of third-generation cephalosporins, 
aniinoglycosides and ciprofloxacin were surveyed and the role of 
extended-spectrum beta-lactamaser (ESBLs) was studied. 
Methods: Antibiotic sensitivities of the strains were determined 
with the disk diffusion method on Mueller-Hinton agar. ESUL were 
detected by the double-disk diffusion test and Etest. Chictic detcr- 
mination of ESUL features was carried out by alkaline lysis of the 
bacterial cells, transformation and conjugation. 
Results: Out of about 600 E .  roli, 140 Klrbtielln and 450 Eritem- 
barter strains, the ratios of resistant isolates ranged 3s follows: 7-1 3% 
of E. coli, 17-40% of Klebsiella spp. and 45-52% of Entcrohacter spp. 
were resistant to third-generation cephalosporins. 5-1 1% of E .  coli, 
8-26‘3) of Klrbsiefla spp. and 8-47% of Enterobartrr cpp. showed recis- 
taiice to aminoglycosides. Further investigation of 106 ceftazidine- 
resistant or intermediate strains revealed R resistance to cefoperazone, 
ceftriaxone, gentamicin, tobrainycin and netilmicin, and a sensitivity 
to imipeneni, meropenem, ciprofloxacin and amikacin. Nine out of 
106 randomly selected ceftazidine-resistant strains proved to be ESBL 
producers. Successful transformations of plasmids from the ESRL- 
producing strains to E. roli DH5alpha resulted in resistance to 
ceftazidime, cefoperazone, ceftriaxone, tobramycin, gentamicin and 
netilmicin, while the transformed cells remained sensitive to 
carbepenerns, ciprofloxacin and amikacin. 
Conclusions: The survey has shown the simultaneous expression 
of aminoglycoside resistance and the ESLlLs. 
Resistance grampositive bacteria 
Macrolide resistance among group A 
streptococci (GAS) and S. pneumoniae (Spn) in 
Belgium 
(PM) and Srrratia nzarcrsrerts (SE) were collected and simultaneously 
tested in duplicate using the diisk diffusion test with NCCLS stan- 
dards. The years were 1991-98, and a total of 2750 strains were 
tested. 
P. Detcheemaeker, S. Chapelle, M. Hauchecorile, M. WiJdooghe, 
P. Vandamme, G. leven, H. Goossens. L’rzivcrrity ofilntwcrp, 
Aritwc’rp, Be[qiirm 
Results: The susceptibility of KP, K O  and EC remained similar 
from 1991 to 1998. For KP and K O  the most active agents were CEF 
and imipenem, and for EC the sanie was true. For PA, CEF and C T Z  
there was a gradual loss of susceptibility over the last 3 years 
(1995-98) to both agents. 
Resistance of GAS and Spn to iiiacrolides is caused by drug efflux 
and target site modification (MLSU phenotype) which can be 
inducible (I-MLSB) or constitutive (C-MLSB). 
One hundred and thirty-one (6.5%) erythromycin-resistant (ERY- 
R) strains (MIC? 1 pg/mL), detected miong 2014 Belgian GAS 
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isolates collected since 1993, and 33 ERY-R (MIC3 1 pg/mL) Spn 
isolates were included. MICs were determined by agar dilution 
according to the NCCLS for ERY, clindamycin, clarithromycin, 
azithroniycin, rovamycin, miocamycin, and H M R  3647. Resistance 
was further classified according to the double-disk method with clin- 
damycin and ERY disks and clonal variability was estimated by PFGE 
and M-typing. 
Of the 131 ERY-R GAS isolates, 110 (84.0%) showed active 
efflux; the remaining 21 (16.0%) belonged to the C-MLSB pheno- 
type. Among the 33 Spn isolates, active efAux was only detected in 
three strains (9.1%) while 21 (63.6%) showed C-MLSB and 9 (27.3%) 
the I-MLSB phenotype. PCR confirmed the presence of mef(efflux) 
or erm (modification) genes in all strains, and PFGE and M typing 
demonstrated a high polyclonal variability among the GAS isolates. 
Typically, all MLSB-resistant GAS showed high-level resistance 
towards all antibiotics tested, except for H M R  3647, where the MIC 
range varied between 0.03 and 4 pg/mL (MICYO 0.5 pg/mL) The 
M-resistant isolates were moderately resistant towards erythromycin, 
clarithromycin and azithromycin, while they remained susceptible 
towards the other antibiotics tested. 
Efflux is the major niechanism of resistance among GAS in which 
Spn target site modification is the principal mechanism. 
Im In vitro susceptibility to antimicrobial drugs in 
viridans streptococci isolated from clinical 
material 
S. Pachkova, M. Sredkova, H. Hitkova, A. Chervenkova. Higher 
Medid Institute, Pleuen, Bulgaria 
Objectives: To evaluate the susceptibility to antimicrobial agents in 
58 S. viridans strains isolated from blood cultures, abdominal and 
pleural exudates, aspirates from lung abscesses, inflammatory pro- 
cesses in maxillofacial region, and tracheal aspirates. 
Methods: The susceptibility to penicillin, ampicillin, cefotaxime, 
ceftriaxone, erythromycin, clindamycin, gentamicin and vancomycin 
was determined by an agar dilution method. 
Results: The strains are distributed as follows: S. mitis (31 strains), 
S. bouis (8 strains), S. mutam (8 strains), S. milleri (7 strains), S. sati- 
uarius (4 strains). Thirty-nine (67.3%) of the tested strains were 
susceptible to penicillin (MIC range 0.06-O.125 pg/niL), 29.3% had 
intermediate susceptibility (MIC range 0.25-2.0 pg/mL) and 3.4% 
were resistant (MIC range 8-32 pg/mL). MIC5o and MICuo ofpeni- 
cillin were 0.06 pg/mL and 1.0 pg/mL. Ampicillin was less active 
compared to penicillin, with MICW and MICro 0.83 pg/mL and 6.6 
pg/mL respectively. The strains showed high susceptibility to clin- 
damycin (MICso=0.03 pg/niL; MICso=0.08 pg/mL), ceftriaxone 
(MICjll=0.09 pg/mL; MICr11=0.2 pg/mL), cefotaxime (MIC5o=O.l 
pg/mL; MICso=0.5 pg/mL) and vancoinycin (MICso=0.4 pg/mL; 
MICs0=0.6 pg/mL), and moderate susceptibility to erythromycin 
(MICj(l=0.04 pg/mL; M I C v d . 8  pg/niL) and gentamicin 
(MICsr,=3. 1 pg/mL; MICw= 12.6 pg/niL). 
Conclusions: These results point to a decreased susceptibility to 
antibiotics used for treatment of infections caused by viridans strep- 
tococci. 
[p8621 Streptococcus mitis with very high level 
penicillin resistance isolated from neonates in 
Kuwait 
P.W.J. West', R. Al-Sawan', H.A. Foster', A. Alex', Q. 
Electricwala', D. Panigrahi' . 'Kuwait University, 'Fanvania Hospital, 
Kuwait; 'University .f &!ford, Sagord, UK 
Objectives: To study the biochemical characteristics, antimicrobial 
susceptibilities and cell surface protein profiles of 'viridans strepto- 
cocci' with very high level penicillin resistance isolated from neona- 
tal blood cultures and endotracheal tube cultures. 
Methods: Five isolates showing very high level penicillin resis- 
tance were speciated using the API 20 Strep, and conventional meth- 
ods. Penicillin minimum inhibitory concentrations (MICs) were 
determined by agar dilution and Etest and oxacillin by Etest. 
Antimicrobial susceptibility was also tested by disk hffusion. Cell 
surface proteins were extracted and separated by polyacrylamide gel 
electrophoresis. 
Results: All the isolates were identified as S. mitis. However, they 
showed differences in carbohydrate fermentation and sialidase activ- 
ity. Penicillin MICs were 64 mg/L by agar dilution and 256 mg/L 
by Etest, as were oxacillin MICs. The isolates showed similar antimi- 
crobial susceptibility patterns, but major differences in zone sizes with 
iniipenem and ciprofloxacin were noted. Cell sudace protein profiles 
were similar, but differences were observed. 
Conclusions: We conclude that high level penicillin-resistant 5'. 
mitis strains are present in Kuwait and that prophylactic treatment of 
neonates with ampicillin and amikacin may favor colonization. The 
differences between our isolates does not indicate cross-infection. 
lp8631 Antimicrobial susceptibility of viridans 
streptococci isolated from blood during 
199Ck98 
C. Jebelean, L. Binder, M. Haditsch, R. Watschinger, H. 
Mittermayer. Department of Medicai Minobioloxy and Hygiene, 
Elisabethinen Hospital, Linz, Austria 
Objectives: In this study we investigated the susceptibility to peni- 
cillin (P), erythromycin (E), chloramphenicol (C), tetracycline (T) 
and trimethoprim-sulfamethoxazole (TMP-SXT) of 134 strains of 
viridans streptococci isolated from blood during 1990-98. 67 strains 
were also tested against clindamycin (CL), levofloxacin, trovafloxacin, 
and linezolid. 
Methods: Isolates were identified with API 20 STREP (Bio 
Merieux). There were 43 S. mitis, 40 S. sanguis, 21 S. saliuarius, 23 
S. milleri group and 15 other species. For antimicrobial testing we 
used the agar dilution method on Mueller-Hinton agar supple- 
mented with 5% sheep blood (lysed horse blood for sulfonamides) as 
recommended by the NCCLS. 
Results: P, E, T and TMP-SXT resistance increased fiom 8%, 
19%, 28% and 16% in isolates from 1990-94 to 19%, 39%, 34% and 
29%, respectively, in isolates from 1995-98. C resistance decreased 
from 27% to 4% in the same period. P-resistant isolates were also 
more frequently resistant to E, T, C and TMP-SXT. The most resis- 
tant species were S. mitis, S. sanguis and S. saliuarius. Of 17 E-resistant 
strains isolated in 1997-98, only 7 also showed resistance to CL 
(MLSB resistance type). Linezolid showed no cross-reaction with E 
and CL and inhibited all strains tested at MIC < = 4  pg/mL. All 
strains tested were susceptible to fluoroquinolones. 
Conclusions: Because of the high prevalence of E-resistant 
strains, macrolides are unsuitable alternatives to penicillin for endo- 
carditis prophylaxis in penicillin-allergic patients. 
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I P865 I In vitro susceptibility of group A beta- 
hemolytic streptococci to macrolides and other 
antibiotics in Poland 
K. Szczypa, A. Kuziniska, W. Hrytiiewicz. S w  and Y,ccines Central 
Research Lnboratoty Warsaiv, Poland 
Objectives: Susceptibility to macrolides and other antibiotics of S. 
pyogenes strains collected in seven centers in Poland was evaluated. 
Methods: Seventy-six of group A beta-hemolytic streptococcal 
(GABHS) isolates were recovered from throat swabs, skin, soft tissue 
and blood. Beta-hemolytic colonies were identified as S. pyofenes 
using a latex agglutination test (Streptex; Murex). MICs were deter- 
mined by the standard microdilution procedure and interpreted 
according to NCCLS criteria. 
Results: The activities of 10 antibiotics (range of MICs pg/mL) 
against S. p y o p w s  strains isolated in 1997 were the following: peni- 
cillin, 0,003-0,015, tetracycline 0.12-16, erythromycin 0.01 5 4 ,  
clarithromycin 0.015-0.25, aiithromycin 0.06-0.5, dirythromycin 
0.06-0.12, spiramycin 0.06-0.5, lincomycin 0.0015-0.25, and chn- 
damycin 0.007-0.06. Tetracycline resistance was observed in 59 
strains (77.6%). Resistance to erythromycin was observed only in 4 
strains (5.2%). Susceptibility to erythromycin was also tested on 100 
strains collected in 1998. Among these, only one strain was resistant 
to erythromyciI1, with an MIC: of 2 mg/mL . 
Conclusions: Although the level of resistance of S. pyogfnes to 
erythromycin remains relatively low in Poland, it is advisable to 
perform monitoring due to the extensive use of this drug. 
lp8661 Erythromycin-resistant Streptococcus 
pyogenes strains isolated in Greece 
E. Tzelepi', G. Kouppari', A. Mavroidi', A. Zaphiropoulou2, L.S. 
Tzouvelekis' . 'Department of Bacteriology, Hellenic Pasteur Institute, 
Athens, 'Microbiology Laboratouy, 'PG A. Kyriakou' Children's 
Hospital, Athens, Greece 
Objectives: To determine the frequency and types of erythromycin 
resistance in Streptococcus p y o p m  and to assess the in vitro suscepti- 
bilities of erythromycin-resistant strains to various l3-lactams. 
Methods: A total of 534 S. pyogenes rtrains consecutively isolated 
from outpatients with pharyngotonsillitis in a pediatric hospital in 
Greece during a 1-year period were evaluated. The isolates were 
identified by conventional methods and API-Strep (Biomerieux); 
erythromycin-resistant strains were determined on the basis of stan- 
dard disk antibiotic susceptibility testing according to the NCCLS 
guidelines and classified into rr~acrolide-resistance phenotypes by an 
inducibility test using erythromycin and clindaniycin disks. Anti- 
biotic MICs were determined IJY the Etest method. 
Results: Resistance to erythroiiiycin was detected in 81 (15.2%) 
of the isolates. O f  the resistant strains, 48% had the inducible MLS 
phenotype and 52% the new M resistance phenotype. lnducibly resis- 
tant strains exhibited lower macrolide MICs (erythromycin 1-8, clar- 
ithromycin 0.5-4 mg/L) than those with the M phenotype 
(erythromycin 8-32, clarithromycin 4-32 ing/L). All the isolates 
were susceptible to clindaniycin and to the &lactam antibiotics tested 
(MIC.,I, values: penicillin G 0.01 6, cefprozil and amoxycillin/clavu- 
lanate 0.023, cefaclor 0.125 mg/L). 
Conclusions: Erythroiiiycin-resistant S. pyqenes  of both the 
inducible and the M resistance phenotypes have been established in 
the Greek community. The Il-l.ictam antibiotics tested retain high in 
vitro activities against this pathogen in our setting. 
-1 Mechanisms of erythromycin resistance in 
Streptococcus pneumoniae strains from 
young Greek carriers 
George A. Syrogiannopoulos, Ioanna N. Grivea, Todd Daviec, 
George D. Katopodis, Francesco Ronchetti, Michael K. Jacobs, 
Peter C. Appelbaum, Nicholas G. Beratis. Univ Patras, Mcdical 
School, Patras, Greece; Hershey Medical Ctr., Hershe)< P A ,  and Casc 
Western Reserve Univ., Cleueland, Oh', USA 
Objectives: We studied the prevalence and mechanisms of erythro- 
mycin (Ery) resistance in Streptococcus pneurnoniae (SP) strains 
from young carriers, living in different areas of Central and South 
Greece. 
Methods: From Feb. 10, 1997 to Aug. 31, 1998, nasopharynged 
cultures were performed in 1997 children (ages 224 iiio, median 12 
mo.). Seventyeight (3.9%) of the cultured children attended daycare 
centers. Penicillin (Pen) MICs were determined by Etect. 
Susceptibility to Ery and clindaniycin (Cli) was tested by disk diffu- 
sion. Ery resistant (R) strains were studied for ern1 and mef gene 
products by PCR. 
Results: Of 648 SP isolates, 18% and 13% were R to Ery 2nd Ch, 
respectively, Seventeen percent of the 648 SP strains were 
Pennonsusceptible 110% intermediate ( l ) ,  7% R], with 51 % oftheni 
being Ery R and 38% CH R. Nineteen Ery R SP strains, repre- 
senting different resistance patterns and serotypes, were tested for ern1 
and mef genes. The erm gene was detected in 14 strains (serovpe 6A 
(I), 6B (4), 11A (2), 19F (2), 23F (3) and not typeable (2)], while 
mefwas found in 5 strains Iserotype 14 (1) 19F (4)). 
Conclusions: (1) 18% of the SP strains isolated from Greek carri- 
ers 224 mo. old were Ery R; (2) 53% of the Ery R strains were Pen 
wsceptible, and (3) among the Ery R tested SP, erm and nlef genc 
products were present in 74% and 26% of the strains, respectively. 
lp867( Resistance to penicillins, aminoglycosides and 
vancomycin in enterococci isolated from 
clinical specimens 
M. Gueorguieva-Sredkova. Hkher Medical Institufe, Pleveri, Bu[qaria 
Objectives: To study by different methods the resistance to peni- 
cillins, aminoglycosides and vancomycin in a large number of ente- 
rococcal clinical isolates. 
Methods: 575 strains of enterococci we;-e tested as follows: by a 
disk diffusion method (DDM); for R-lactamase production; by agar 
screen methods for accurate detection of high-level aminoglycoside 
resistance (HLAR) and resistance to vancomycin (VA). The MICs for 
the strains resistant to penicillins and VA were determined by an agar 
microdilution method and a broth dilution method. 
Results: Nearly half of E. jaecium strains showed resistance to 
penicillin (PE) (48.2%) and ampicillin (AM) (42.8%). In E. j r a l i s  
strains, resistance to both penicihns was about 2%. Thc range of 
MICs for PE and AM for the resistant E. Jccalis strains were 16-128 
pg/niL and 32-64 pg/mL, and for the resistant E.facacium strain< they 
were 16-256 pg/niL and 16-128 pg/iiiL. All strains were fi-lacta- 
mase negative. High-level resistance (HLR) to streptomycin (SM) 
and gentaniicin (GE) showed in 41.7% and 31.1Vi ofthe strains. H L R  
to both agents was detected in 23.7% of E. jecalis isolates and 19.6% 
of E. faecium isolates. Ten (1.7%) of the strains had internledlate 
susceptibility to VA (MIC=8 pg/mL). DUM was effective for detect- 
ing the resistance to penicillins and HLAK but it was not reliable 
enough for detecting low resistance to VA. 
Conclusions: Our  data show a high frequency of HLAR in E. 
fecalis and E. .faecium and high prevalence of resistance to penicillins 
in E. fuecium. Intermediate susceptibility to VA is still rare in both 
species 
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lp868) Susceptibility patterns in 4208 European 
enterococcal strains 
C.J.M. Bartels, H.J.G.R. Roelofs-Willemse, A. Voss. Department .f 
Medical Microbiology, University Hospital St Radboud, Nijmegen, T h e  
Netherlands 
Objectives: To determine antimicrobial susceptibility patterns in 
clinical enterococcal isolates collected in 27 countries. 
Methods: During the first quarter of 1997, participants in 49 
hospitals from 25 European countries, Israel and Turkey collected 
4208 clinical enterococcal strains from different patients (maximum 
100 strains per center) together with clitllcal data. Species identifica- 
tion and susceptibility testing by microbroth dilution (NCCLS) was 
performed in our laboratory. Susceptibility to currently used and 
investigational glycopeptides, quinolones, and 8-lactam antibiotics 
and 8 other drugs was tested. 
Results: Vancomycin resistance (MIC 8mg/L) was seen in 0.4% 
of all strains (VRE). MICsos (mg/L) of VKE for other drugs were as 
follows: LY 333328 2, everiiinomicin 2, quinupristin-dalfopristin 
(QD) 4, trovafloxacin 8, Bay 128039 16, amoxycillin 32, sparfloxacin 
32, imipenem 128, teicoplanin 128, and cefpirome 128. High- 
level gentamicin resistance (HLGR) was seen in 25% of VRE. 
Vancomycin-susceptible strains (VERSUSE) showed HLGR in 20%. 
MICWS of VERSUSE were comparable with those of VRE except 
for amoxycillin 2, imipenem 8, and teicoplanin 0.25. A higher MICw 
was seen for QD:  8. 
Conclusions: HLGR varies from 20% in VERSUSE to 25% in 
VRE. VRE prevalence is low. VKE show in vitro susceptibility to 
LY 333328, everninomicin, and QD. These antibiotics might be a 
useful alternative for the treatment of infections with VRE. 
lp8691 Resistant enterococci isolated from blood 
cultures in a Portuguese hospital 
G. Ribeiro, C. Vital, C. Vieira, C. Pontes, D. Costa. Laboratbrio de 
Microbiologia, Hospital da Uniuersidade de Coimbra, Coimbra, Portupl 
Objectives: To evaluate the frequency and glycopeptide resistance 
of Enterococcusfecalis and Enterococcusfaecium isolates from blood, over 
a 4-year period. 
Methods: A total of 33 904 aerobic Vital blood cultures were 
performed between 1994 and 1997. Enterocorcus Lfecalis and faecium) 
represented 5.8% (235) of all blood isolates (1.082). All strains were 
identified with GPI (Vitek) and API 32 Strept (ATB). The suscepti- 
bility tests were performed with GPS I Q  (Vitek) and the Etest 
method was used to detect vancomycin and teicoplanin resistance. 
High-level resistance to aminoglycosides was determined with the 
Kirby-Bauer method. 
Results: Enterococcus isolates, one per patient, were as follows. 
1994: E. fecalis=34, E. f aec ium=l l .  1995: E. fecalis=45, E. 
faecium=13. 1996: E. fecalis=54, E. faeciurn=8. 1997: E. fecalis=44, 
E.faecium=26. Resistance rates of E.fecalis were: ampicilin 0%, strep- 
tomycin HL 42%, and gentamicin HL 29%. E. faecium was more 
significantly resistant to ampicillin 85%, streptomycin HL 6594, and 
gentaniicin HL 35%. 14 of all strains (10 E. faecium and 4 E.  fecalir) 
were resistant to glycopeptides (vancomycin and teicoplanin), 1 in 
1994, 4 in 1995, 4 in 1996, and 5 in 1997. These GRE strains were 
provided from 9 dialyzed patients, 2 from the transplant unit, 2 from 
the hematology unit and 1 from the ICU. 
Conclusions: Glycopetide resistance was not detected before 
1994 in our hospital. Increasing frequency of glycopeptide resistance 
is observed in Enterococcusfaecium isolates from blood cultures. Most 
GRE strains were isolated from dialyzed patients. It is necessary to 
control the spread of these inultiresistant strains in hospital wards. 
(p8701 Species identification and antibiotic resistance 
of Enterococcus clinical isolates 
V. Skandami, M. Toutouza, H. Fakiri, l? Kapnopoulou, Z. 
Komninou. Microbiology Department, “Hippokration” General 
Hospital, Athens, Greece 
Objectives: To determine the species distribution of enterococci 
isolated from hospitalized patients and their resistance phenotypes. 
Methods: A total of 112 clinical isolates of enterococci were 
collected during a 6-month period aanuary to June 1997) from 
patients treated in our hospital. Strains were isolated from urine 
52.6%, blood cultures 8.9%, hepatic abscess 8.9%, pus 12.5%, and 
other specimens 17.1%. Identification to the species level was 
performed with the ATB system (Rapid ID 32 Strept, Bio-Merieux, 
France) and antibiotic susceptibility was determined by two meth- 
ods, the duk dffusion method according to NCCLS guidelines and 
the automated ATB antibiogram system . 
Results: O f  the strains tested, 72 were identified as Enterococcus 
fecalis and 40 as Euterococcusfaecium. The percentages of resistance to 
antibiotics were for E. fecalis and E .  faecium respectively: penicillln 
38.9% and 65%, ampicillin 13.9% and 65%, gentamicin high level 
(HL) 34.7% and 17.5%, streptomycin HL 44.5% and 42.5%, and 
kanamycin HL 59.7% and 80%. All isolates were vancomycin and 
teicoplanin susceptible. The most common phenotypes of resistance 
were for E.fecalir P, GEN, STR, KAN (25%). P, AM, KAN (9.7%), 
and GEN, STR, KAN (9.7%), and for E. fecium P, AM, KAN 
(37.5%), P, AM, STR, KAN (17.5%), and P, AM, GEN, STR, KAN 
Conclusions: The majority of E.faecium isolates tested were resis- 
tant to both penicillin and ampicillin. O n  the other hand, E. fecalis 
isolates remain susceptible to ampicillin. Moreover, enterococci resis- 
tant to high-level aminoglycosides and especially to kanamycin are of 
high incidence. N o  glycopeptide resistance was seen in our study 
(10%). 
Ip8711 Significant increase of erythromycin-resistant 
pneumococci in Upper Austria 
C. Jebelean, R. Watschinger, L. Binder, M. Haditsch, H. 
Mittermayer. Deparfmenl of Medical Microbiology and Hygiene, 
Elisabetkinen Hospital, Linz, Austria 
Objectives: We periodically monitored the antimicrobial resistance 
of pneumococci isolated in our laboratory. In this study we investi- 
gated the susceptibility to penicillin (P), erythromycin (E), tetracy- 
cline (T), chloramphenicol (C) and trimethoprim-sulfamethoxazole 
(TMP-SXT) of 134 strains of pneumococci isolated in our labora- 
tory during 1997 and 1998. 62 strains were also tested for clin- 
damycin, levofloxacin, trovafloxacin and linezoiid. 
Methods: We used the agar dilution method on Mueller-Hinton 
agar supplemented with 5% sheep blood (for sulfonamides: lysed 
horse blood) and the breakpoints recommended by the NCCLS. 
Results: The rates of P, E, TMP-SXT, C and T resistance in 
pneumococci were 1%,10%, 3%, 2% and 13% respectively, in 
1997-98, compared to 15%, 2%. 3%, 1% and 7% respectively, in 
1991-96. Half of the pneumococci resistant to E in 1997-98 were 
also clindainycin resistant, suggesting an MLSB resistance pattern. 
Linezolid did not show any cross-resistance with macrolides and 
lincosamides. All strains tested were susceptible to levofloxacin and 
trovafloxacin. 
Conclusions: In the isolates from 1997-98 we found a decrease 
in the rate of P resistance and an increase in the rate of T and espe- 
cially E resistance; noteworthy is the fact that the E resistance was not 
related to penicillin resistance las in the isolates from 1991-96. 
A b s t r a c t s  
Penicillin Cefotaxime 
Resistant 21(14%) 1(1.53%) 
intermediate 49 (32%) 26 (ITYO) 






lp8721 Different association of aminopenicillin, 
cephalosporin and rnacrolide resistance with 
penicillin resistance in S. pneumoniae in Spain 
Antimiaabial Susceptible strains Intennwtep 
Penicilli G 565 I593 (95.3) 27 1593 (4.5) 
Ceftriaxme 591 / 593 (W.6) 1 I593 (0.2) 
Erythromycin 5411593 (92.2) 91593 (1.5) 
Rihpicin 593 I593 0 I 593 
agent (%) resist. s h n s  h) 
J. Garcia de Lomas', L. Aguilar Alfai-02, J.J. Granizo', the Spanish 
Surveillance Group for Respiratory Pathogens. 'Instiruto Valrrzirano 
de Mirrubiolqia, 'Medical Departtnent, SniitkKlinc Beecham, Madrid, 
Sl'ain 
Objectives: In order to assess the association between antimicrobial 
resistance to diffei-ent antimicrobials with penicillin resistance, preva- 
lences of resistance to inacrolides, cephalosporins and aminopeni- 
cillins were calculated for penicillin-susceptible (Pen-S), intermediate 
(Pen-I) and resistant (Pen-R) strains. 
Methods: Antimicrobial susceptibility data of 11 13 isolates of 
Streprococcus pneumoniae collected between May 1996 and April 1997 
from a nationwide surveillance study of susceptibility involving 14 
ho5pitals were used. All the strains were from patients with commu- 
nity-acquired respiratory tract infections and were tested against 12 
commonly used antimicrobials in Spain. 
Results: Resistance prevalence to selected antimicrobials by peni- 
cillin susceptibility: 
Pen-S Pen-I Pen-R 
Amox-dav. 0 % 4 %  62 % 
Cefuroxime 0 % 40 Yo 100 % 
Cefotaxime 0 % 2 % 34 % 
Erythromycin 6 % 51 % 53 % 
Conclusions: Macrolide-cefuroxime resistance associated with 
penicillin resistance appears in both Pen-I and Pen-R categories, 
whereas the aminopenicillin and third-generation cephalosporin 
resistance association with penicillin resistance is only shown in the 
Pen-K strains. 
H I I @ ~ $ .  - 
I I593 (0.2) 
1 I593 (0.2) 
371593 (6.3) 
0 I593 
1-1 Antimicrobial resistance of Streptococcus 
pneumoniae in a large southwestern German 
community hospital, 1992-98 
J. Abb. Iiistitufr of Miirobiolqy, Kliniknrn Ludiuigsbuv, Ludwksbrrrg, 
Germmy 
Objectives: To assess the prevalence of pneumococcal resistance to 
antimicrobial agents over a 6-year surveillance period. 
Methods: Five hundred and ninety-three primary clinical isolates 
of pneumococci were collected from hospitalized patients between 
October 1992 and October 1998. Minimal inhibitory concentrations 
(MICs) for penicillin, ceftriaxone, erythromycin, and rifanipicin 
were assessed by the Etest. MIC: values were converted to categories 
of susceptibility by using the NCCLS standard M100-S 8. 
Results: Data of MIC determinations are sumniarized in the 
table: 
Prevalence of antibiotic, resistance of S. pneunonioe 
Resistance rate5 to penicillin remained remarkably constant over 
the 6-year surveillance period Resistance rates to erythromycin, 
howevei-, showed a more than threefold increase from 4.2%) during 
winter 1992/93 to 14.8% during winter 1997/98. 
Conclusions: The recent increase of pneumococcal resistance to 
macrolides underlines the need for continuous surveillance of antinii- 
crobial susceptibility of Strrptucoccu, pneumoniae as a guide to appro- 
priate treatiiient of pncuniococsal infections. 
lp874) streptococcus pneumoniae (sp): resistance 
rates during 1998 in isolates from Attica, 
Greece 
E. Xirouchaki', P. Grecka', M. Grainniatikou', 1. Ihskalaki', A. 
Mandaraka', A. Tsitsika' , K. Kanellakopoulou', H. Giamarellou'. 
' Departmetit cf Hygiene and Epidemiufu~qy, '4th Dpr t rnenf  tf Ititcrrial 
Medicine, 
Atlirrrr, Greece 
Objectives: The estimation of current resistance rates of Sp isolates 
in Greece in both healthy carriers and patients. 
Methods: 84 Sp strains fmm healthy carriers (216 adults and 434 
children, aged 3-7 years) isolated over winter 1998 in Athens and i t s  
metropolitan area were evaluated by the Etest. 
Results: Respective resistance and intermediate resistance to 
penicillin G (P) and erythromycin (E) were 0 and 20% and 17.3 and 
3.7%. MlCirl-MICsl, of P, ceftriaxone, E, clindamycin, vanconiycin, 
ciprofloxacin, grepafloxacin, trovafloxacin, quiiiupristin/dalfopristin 
and linezolid were 0.01 2-0.25, 0.016-0.1 9, 0.19-4, 0.1 25-0.75, 
0.5-1, 0.75-1.5, 0.19-0.38, 0.094-0.19, 0.75-1.5 and 0.25-1 g/mL 
respectively. 
Conclusions: (i) Continuous surveillance of resistance is manda- 
tory, (ii) P should not be prescribed for life-threatening infections, 
and (iii) trovafloxacin seems the niost promising newer compound 
against Sp. 
1st Dcpartnretir of Prop. Medicirre, Athrtis Medical Scltoul, 
lp8751 Susceptibility to penicillin, cefotaxime and 
erythromycin in clinical isolates of 
Streptococcus pneumoniae in a Spanish 
teaching hospital 
N. Prieto, B. Uuendia, I? Vargas Diaz, T. Delgado, M. Lhpez-Urea. 
Departmetit qfMicro/kdogX Hospital Universitario dc la Priniesa, 
Madrid, Spnirz 
Objectives: To determine the susceptibility to penicillin, ccfotaxime 
and eiythroiiiycin in clinical isolates of Strtpcaccus pneurnoniae (Sp) 
from January 1997 to August 1998, in a 5C)O-bed teaching hospital in 
Madrid. 
Methods: One hundred and fifty-thrce clinical iwlates of Sp were 
studied. The isolates were identified by optochin disk. The in vitro 
activity of penicillin and erythromycin was studied by the disk diff~l- 
sion inethod as recommended by the NCCLS. The strains with inhi- 
bition zone diaiiieter <19 niin to oxacillin (1-pg disk) were tested 
for susceptibility to penicillin and cefotaxinie by Etest strip accord- 
ing to the inanufacturer's instructions, and incubated at 35OC in a 
10% CO? atmosphere. The breakpoint of suqceptibility was defined 
as recommended by the NCCLS. 
Results: The table shows the number and percentage of Sp resis- 
tant, intermediate and susceptible to the antibiotics tested: 
Conclusions: This study shows a reduced susceptibility to penicillin, 
cefotaxiine and erythromycin in Sp and these results are in agreement 
with the percentage of resistance in Spanish clinical isolates.The 
increase ofthe resistance ofSp points to the necessity for continuous 
surveillance of the susceptibility of these microoorgaianisms by 
currently available methods. 
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1m63 Antibiotic resistance in Streptococcus 
pneurnoniae isolated in a clinical hospital 
during 1997-98 
0. Dorobat, T. Biolan, M. Burtea. Clinical Microbiology Laboratory, 
Clinical Hospital o f  Infectious Diseases Dr V Babes, Bucharest, Romania 
Objectives: To compare the resistance of Streptococcus pneumoniae 
recovered from patients and carrier, HIV and non-HIV. 
Methods: A total of 461 Streptococcuspneumoniae (91 HIV patients, 
129 HIV carrier, 169 non-HIV patients, 72 non-HIV carrier) were 
tested using the NCCLS disk diffusion technique for oxacillin (OX), 
amoxycillin/clavulanate (AMC), cefiriasone (CRO), chlorampheni- 
col (C), tetracycline (T), erythromycin (E), rifampicin (RD), 
ofloxacin (OFX), vancomycin (VA) and imipenem (IPM) with 
Streptococcuspneumoniae ATTC 49619 as a control. The MIC ofpeni- 
cillin was determined by the agar dilution method for 119 strains and 
by Etest for 30 oxacillin-resistant strains. 
Results: Resistance (%) by the disk diffusion method was as 
follows: 
OX AMC CRO C TE E RD OFX 
HIVpatiens 64.8 0 0 3.3 19.7 36.2 45 19.7 
Non-HWpaticnu 35.5 0 0.6 13 37.8 31.9 10 3.5 
HIVcarrier 75.2 0.6 0.7 13.1 37.9 59.6 612 27.9 
Non-HIVcanier 38.8 0 0 11.1 41.6 31.5 9.1 0 
To VA and IPM there was no resistant strain. The MIC of peni- 
cillin was 2 pg/niL in 62.2% ofstrains and between 0.12 and 1 pg/mL 
in 37.8% of strains. The Etest showed only in two cases an MIC of 
2 pg/mL for the isolates with 1 fig/mL in the ddution method. 
Conclusions: There are differences between Streptococcus pneumo- 
niae isolated from HIV and non-HIV. The resistance is higher in HIV 
strains for penicillin, erythoniycin, rifampicin and ofloxacin. 
lp8771 Evaluation of a new method, pneumo PAC, for 
determination of MICs of penicillin G, 
amoxycillin and ceftriaxone against 
pneumococci 
R. Leclercq', M. Auzou', D. Tandk', L. Lode', V Loncle-Provot'. 
'CHU, Caen, zCHU, Brest, 'Sanofi Pasteur, Cam, France 
Objectives: To evaluate the performances of pneumo PAC, a new 
method for susceptibility testing of Streptococcus pneumoniae to beta- 
lactams. 
Methods: Two hundred clinical strains of Sfreptococcus pneumoniae 
isolated in various French hospitals from western France were tested. 
Forty-five were susceptible to penicillin G (MIC <0.12 mg/L) and 
155 strains were intermediate or resistant to this antibiotic (MIC 1 
mg/L). MICs of penicihn G, amoxycillin and cefiriaxone were 
determined by pneumo PAC in comparison with three different 
techniques, the NCCLS microbroth dilution, agar dilution and the 
Etest. In addition, MICs of antibiotics were determined directly using 
dilutions of cerebrospinal fluid (CSF) and blood cultures positive with 
pneuniococci. The rapidity and the ease of MIC readings were also 
recorded. 
Results: The results were analyzed in terms of essential agreement 
(2 1 dilution ). For all the antibiotics tested, an absolute quantitative 
agreement ranging from 96% to 100% with the three different meth- 
ods was observed. MICs obtained after 6 or 8 h of incubation corre- 
lated with overnight MICs for 90% of the strains. When pneumo 
PAC was directly performed on CSF or blood cultures, the MICs 
were 100% in agreement with those obtained from isolated colonies. 
Reading of color change from blue to pink, and resulting MIC with 
the pneuino PAC method, was easy and highly correlated between 
eight independent observers. 
Conclusions: Pneumo PAC provides a valuable method for 
susceptibility testing of pneuniococci to beta-lactams. 
1-1 Use of clindamycin disks to predict high-level 
clarithromycin resistance in Streptococcus 
pneumoniae 
K. Waites, C. Johnson, S. Banks, E. Brookings, B. Gray, K. 
Edwards, M. Crain. University of Alabama at Birmingham, 
Birmingham, A L ;  Spartanburg Rqional Healthcare System, Spartanburg, 
SC;  Vanderbilt University, Ntzshville, TN,  U S A  
Objectives: To determine whether 2-mg clindamycin disks are reli- 
able for differentiating high-level macrolide resistance associated with 
ribosomal methylase (erm) from lower-level resistance due to efRux 
(meJ in S. pneumoniae (SP). 
Methods: 137 non-duplicate SP respiratory isolates were tested 
for susceptibility to clindamycin (CM) by disk &ffusion and to clar- 
ithromycin (CH) and CM by Etests using National Committee for 
Clinical Laboratory Standards interpretive criteria. 
Results: 81 (59%) and 122 (89%) SP were susceptible to C H  and 
CM, respectively by Etest, with 100% concordance for CM disk 
susceptibility. All CH-susceptible SP were susceptible to CM. 15 
CM-resistant isolates were highly resistant to C H  (MICs 256 
mg/mL). 41 CH-resistant but CM-susceptible isolates had CH MICs 
64 mg/mL and MICso=8 mg/mL. 
Conclusions: CM resistance measured by disk diffusion predms 
high-level resistance to CH, whereas CM susceptibility in CH-resis- 
tant SP indicates lower-level C H  resistance. Identification of lower- 
level C H  resistance in SP in a rapid and economical manner may have 
therapeutic implications in view of the ability of C H  to concentrate 
in the lower respiratory tract. Studies are in progress to determine the 
presence of erm and mefgenes in these isolates to validate further the 
use of CM disk susceptibility as a predictor of specific macrolide resis- 
tance mechanisms. 
Lp8791 Multidrug-resistant (chloramphenicol, 
tetracycline, erythromycin, clindamycin, 
trimethoprim-sulfamethoxazole) penicillin- 
sensitive Streptococcus pneumoniae (CTECs) 
in central Italy: 1996-98 
F. Konchetti', M.P. Ronchetti', E Guglielmi3, R. Filipo', M.K. 
Jacobs4, R. Konchetti". 'ENT Department, 'Infectious Disease 
Department, '2 nd Pediatric Clinic, University 'La Sapienza', Rome, 
Italy; 'Case Wexfern Reserve University, Cleveland, O H ,  USA 
Objectives: Understanding the genetic relatedness of the unique 
antibiotic resistance pattern CTECs among Streptococcus pneumoniae 
in central Italy. 
Materials: Strains of CTECs Streptococcus pneumoniae, isolated 
from nasopharyngeal swabs of healthy day-care children aged 3 to 5 
years: (1) in the period 1995-96 in central Italy (19); (2) in 1997-98 
in central Italy (14). 
Methods: Strains were serotyped and analyzed by means of 
pulsed-field gel electrophoresis (PFGE). 
Results: (1) All CTECs strains isolated in 1995-96 were type 6. 
Those strains were genetically related (by PFGE) with Greek and 
Israeli strains and named the 'Mediterranean clone'. Although 6 
PFGE types could be identified, all strains were closely related by 
PFGE. (2) Of the 14 strains isolated in central Italy in 1997-98, only 
4 were serotype 6, the others being 4 serotype 19, 3 serotype 23 and 
3 non-typeable. Although the 4 serotype 6 strains were closely 
related to strains isolated in previous years, the CTECs strams of 
A b s t r a c t s  32 1 
different serotypes showed a completely unrelated genetic pattern by 
PFGE. 
Conclusions: The unique antibiotic resistance pattern CTECs 
has now been found among several genetically unrelated Streptococcus 
pneumoniae clones not only in t.he 'Mediterranean Clone' serotype 6 
but also among strains of different serotypes. 
ml Comparative in vitro activity of fusidic acid and 
frequently used antibacterials against 
staphylococci that were isolated in various 
Turkish hospitals, 
B. Altun, S. Kocagoz, 0. Uzun, M. Akova, S. Unal, H.E. Akalin, 
TUBITAK Project Collaborative Centers. Department of Infectious 
Diseases, School uf Mediiine, Hacettepe University, Ankara, Turkey 
Objectives: Fusidic acid has recently been marketed in Turkey. In 
this study, resistances to fusidic acid and frequently used antibacteri- 
als in 352 staphylococcal strains which were isolated from 23 hospi- 
tals in various regions of Turkey were evaluated. 
Materials and methods: The Kirby-Bauer disk diffusion 
method was employed to detect the in vitro activity of fusidic 
acid, erythromycin, ofloxacin, trimethoprim/sulfamethoxazole and 
sulbactam/ampicillin according to NCCLS criteria. O f  these strains, 
250 were coagulase positive and 102 were coagulase negative. Gram 
staining, catalase and coagulase were used for identification. Most of 
these strains were isolated from blood, pus, respiratory tract and cere- 
brospinal fluid. 
Results: The overall fusidic acid resistance was 5% in methicillin- 
resistant Staphyloioccus aureus and 10% in methicillin-resistant coagu- 
lase-negative staphylococci. We did not find any resistance to this 
antibacterial in methicillin-sensitive coagulase-positive and c o a p -  
lase-negative strains. 
Conclusions: The low resistance rates of methicillin-resistant 
staphylococci to fusidic acid are not surprising, since these strains 
were isolated before this drug was marketed. Therefore this drug can 
be considered for the treatment of staphylococcal infections in our 
country. 
Prevalence of antibiotic resistance in 
staphylococci from patients with bacteremia in 
German tertiary care hospitals 
C. von E i P ,  R. Reinert', G. Peters', for the Study Group. 
'Medical Micro6iolofl, University ($ Munster, Munster, 'Medical 
Micr06iolq~ Aachen, Germany 
Objectives: (I) To investigate the prevalence of antibiotic resistance, 
and (11) to compare the in vitros activity of quinupristin-dalfopristin 
(Q-D) with other appropriate antibiotics against staphylococcal 
blood culture isolates. 
Methods: During a 2-year period, S. aureus and coagulase-nega- 
tive staphylococci (CoNS) were prospectively collected in 17 
German university laboratories. CONS were only included if they 
were recovered from at least two separate sets of blood cultures. 
Minimal inhibitory concentrations were determined using the broth 
microdilution method. 
Results: In 848 patients S. aiireus and in 349 patients CoNS were 
isolated. In 127 patients methicillin-resistant S.  aureus (MRSA) were 
isolated (normal wards 59; ICU 52; other wards 16). Overall resis- 
tance rates for the antibiotics tested against S. auieus and CoNS were 
as foilows: oxacillin 15%d63.0%, erythroniycin 18.2%/62.5%, chn- 
damycin 8.4%/37.0%, gentamicin 12.6%/55.0%, teicoplanin 
0%/1.4%, vancomycin 0%/0%, and Q-D 0%>/0% Among CoNS, 43 
teicoplanin-intermediate (MIC=X nig/L), 5 teicoplanin-resistant 
(MIC=16 ing/L) and 2 vancomycin-intermediate (MIC=8 mg/L) 
strains were observed. Eight strains of S. anreus and 4 CONS were 
intermediate against Q-D (MIC=2 nig/L). Among S. atireus, 70 
strains, and among CoNS, 102 strains, were of the MLS13 constitu- 
tive phenotype. 
Conclusions: Compared to previous data from Germany, our 
results indicate an increase of oxacillin resistance in S. U I I ~ ~ L I S .  The 
new streptogramin antibiotic quinupristin-dalfopristiu showed 
excellent in vitro activity against methicillin and constitutively MLSll 
resistant staphylococci. 
lp8821 In vitro activity of Synercid (SYN) against 
clinical isolates of staphylococci in comparison 
to other antimicrobial agents 
D. Petropoulou-Mylona', G. Adamis', A. Strouza', J. Kosmidis'. 
'Department .f Microbiology, 'First Department cf.bfedirine, Disrrit 
General Hospital offAthens 'G. Gennimatas', Afkerrs, Greece 
Objectives: To compare MICs of Synercid (SYN) to those of other 
antimicrobials for various clinical strains of  Staplrylomccrrs spp. isolated 
from hospitalized patients and outpatients 
Methods: 50 consecutive staphylococcal strains, clinically signif- 
icant, derived from different body sites and infection types, were 
examined, including 31 S. aureiu, 10 S. cpidermidis, 5 S. hucniolytinrs 
and 4 other coagulase-negative staphylococci (CNS) by Etrst in 
comparison with vancomycin, erythromycin, clindaniycin, gentain- 
icin and ciprofloxacin. S. aureus UA188, UA238 and S. liaernolyticus 
UA278 were used for quality controls. Strains with SYN MIC < 1 
were considered sensitive, 2 intermediate and 4 resistant. 
Results: MIC5o MICw (range) in mg/iuL for SYN were as 
follows: 
Isolates MlCm MICqa Range 
Methwllin sen5 S aureus 0.38 0.50 0.25-0.75 
0.75 0.25-1.5 Methicillin res!sl S aureus 0.50 
Methmllin sons S eplderm;d!s 0.25 0.38 0.325~0 5
Melhicillin resat. S. epidenmdis - 0.25-1.5 
Methicillin resist S 0.50 
haemoIVtlcos 
Methlcillln sen$. S CNS 




Vanconiycin MIC was <2 mg/mL (sensitive) on all strains tested. 
There were 35% of the S. a u r a s  and 60?4 of the CNS susceptible to 
erythromycin, 38.7% and 70% susceptible to cliiidamycin and cipro- 
floxacin and 51.5% and 60% susceptible to gentaniicin rcspectively. 
Conclusions: SYN showed the highest activity against MS and 
M R  staphylococci. Only one M R  S. hamolyticus strain had a SYN 
MIC of 4. SYN may be an alternative to vancomycin for the treat- 
ment of infections caused by MRSA and MRCNS. 
lp8831 Discrimination between R-lactamase- 
overproducing and MecA-positive 
Staphylococcus aureus strains 
B. Konig, W. Konig. Inrtitutfur Medizinisrhr Mihrohiologic, Offo-voii- 
Guericke- Universitat Ma~qdebutq, Magdebtrrg, Gernrariy 
Objectives: Detection of oxacillin resistance, which is primarily 
mediated by the mec gene detcrminant, in staphylococci continues to 
be a problem. Oxacillin-resistant isolates of  Stupliylorocrns uurrids with 
borderline MICs (2-8 pg/niL) may contain the mecA resistance gene 
determinant or may produce high levels of fl-lactaniase. While 
vancomycin would be the drug of choice for the mccA-positive 
strains, B-lactamase hyperproducers can be treated with combinations 
of penicillinase-stable B-lactams and B-lactainase inhibitors. We 
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analyzed the accuracy of the VITEK, an automated susceptibility 
testing system, for monitoring the resistance mechanism to oxacillin. 
Methods: We used 48 penicillin-resistant and O-lactamase- 
producing Staphylococcus aureus isolates. These strains were analyzed 
for oxacillin resistance by (a) oxacillin agar screen plate (4% NaC1, 6 
pg/mL oxacillin), (b) the VITEK (GPSSlO), (c) the Etest, and (d) 
PCR for the m e d  gene. 
Results: Among the strains tested, 86.8%/73.7%/75%/52.3% 
were resistant for oxacillin by the oxacillin screening plate/VITEK (2 
pg/mL)/Etest/mecA gene. With regard to the MICs determined by 
the VITEK, all mecA-positive strains had MICs of 8 pg/mL. Using 
the Expert system of the VITEK, the combination of oxacillin and 
gentamicin resistance is concordant with a positive m e d  gene detec- 
tion. 
Conclusions: The VITEK system presents a method for the 
detection of 'true' oxacillin-resistant strains harboring the mecA gene 
and for a rationai therapy. 
ip884) In vitro susceptibility of histotoxic clostridia 
G. Feierl', U. Eihel', EM. Smoue-Juttnes, H. Pinte?, B. Sixll, E. 
Daghofer', A. Grisold', E. Marth'. 'Institute CfHyZiene, University cf 
Grar ,  'Klinische Abteilungfiir Thorax- und hyperbare Chirurgie, 
Universith'tsklinik Graz, Graz ,  Austria 
Objectives: Clostridium pefringens and other histotoxic Clostridium 
spp. may cause life-threatening gas gangrene. In case of infection, 
surgical debridement and hyperbaric oxygenation is the primary 
therapy, but antibiotics are administered also and different substances 
are recommended. 
Methods: To test the antibiotic susceptibility of Clostridium spp., 
we used the Etest for testing 12 antibiotics and ATB ANA with the 
prefabricated combination. The tests were performed according to 
the instructions of the manufacturers. 
Results: By Etest we obtained the following results for 76 C. 
pefringens strains tested: 
A problem was seen in reading MICs of swarming bacteria like C. 
septicum. With ATB ANA, all tested clostridia (n=92) could be deter- 
mined, and concerning C. perfringem a good correlation was seen 
with the results of the Etest. In 36 strains tested there was a reduced 
susceptibility to clindamycin. 
Conclusions: O-Lactam antibiotics have very good activity 
against Clostridium spp,, but the resistance rate of clindamycin was 
surprisingly high. The empirical routine use of clindamycin should 
be reconsidered. 
lp8851 vancomycin resistance in a clinical isolate of 
Bacillus sp. in South Africa 
A. von Gottberg, W. van Nierop, M. Smith, B. Bhagoobhai, S. 
Kaka, A. Duse, R. Smego. Division ofHospifa1 Epidemiolgqy and 
Infection, South African Institute for Medical Research, Houzhton, South 
Africa 
In October 1998 a Barillus sp. was isolated from a blood culture taken 
on admission from a patient diagnosed with pulmonary tuberculosis 
at a state hospital in Gauteng, South Africa. The isolate was thought 
not to be of clinical significance. The organism had terminal and 
subterminal spores and was indole positive. Further identification was 
done using conventional biochemical profiling. Although some reac- 
tions were atypical, a provisional identification of B. alvei was made. 
Confirmation of this identification using 16s ribosomal DNA 
sequencing and further phenotypic characterization is pending. The 
isolate was resistant to vancomycin. MICs for the following drugs 
were established: vancomycin 64 mg/L; teicoplanin 16 mg/L; ampi- 
cillin 4 mg/L; and gentamicin 2 mg/L. Multiplex screening PCR 
commonly used for vancomycin-resistant enterococci was performed 
and indicated the presence of the vanA genotype. The vanA geno- 
type has been described previously in B. circulanr where it has been 
demonstrated to be chromosomal in location. Enterococci with the 
vanA genotype have only recently been reported in South Africa. 
Documentation of the presence of this gene in a Bacillus sp. is of 
importance in elucidating the mechanism(s) of vancomycin resistance 
in Gram-positive organisms and needs to be investigated further. 
Tracking antimicrobial resistance in Gram- 
positive bacteria using The Surveillance 
Network (TSN) Database 
M.E. Jones, D.F. Sahm, I.A. Critchley, M.K. Marsilio, G. Piazza, C. 
Thornsberry. MRL Pharmaceutical Services, Utrerht, The Netherlands, 
and Herndon, Virginia, VA, USA 
Objectives: We anlayzed resistance trends of Gram-positive bacteria 
using the The Surveillance Network (TSN) Database-USA, an elec- 
tronic system combining state-of-the-art information technology 
with microbiological expertise. 
Methods: TSN Database is a repository of nullions of in-depth 
strain-specific routine antimicrobial test results reported daily via 
country-specific networks of institutions. In November 1998, TSN 
Database-USA contained 16 854 881 susceptibility test results from 
1 222 080 strains and 813 627 patients, provided by 154 US institu- 
tions for 91 drugs. Data for the period 1995-98 were analyzed using 
on-line TSN analysis software and NCCLS breakpoint criteria. 
Results: Methicillin resistance increased from 33% to 40% among 
78 714 inpatient strains and from 14% to 24% from 48 526 outpa- 
tient strains of Staphylococcus aureus (SA). Strains with vancomycin 
MIC 4 mg/L were more common among methicillin-resistant coag- 
ulase-negative staphylococci (CNS) (3.0%, n=48 201) than methi- 
cillin-susceptible CNS (0.6%, n=31 553),  MSSA (l.l%, n=67 431) 
or MRSA (0.3%, n=29 800). The ratio of Enterococcus fecalis to 
Enterococcus faecium decreased from 5: 1 to 3: 1. Ampicillin resistance 
among E.Jaeciurn increased from 69% (n=537) to 86% (n=3214) but 
remained under 2% for Efecalis. Increasing high-level penicillin resis- 
tance in pneumococci (14 -19%) was associated with increasing 
macrolide resistance. TSN Database tracks 520 species, thus allowing 
resistance trending for rarely isolated organisms. In viridans strepto- 
cocci, erythromycin resistance doubled from 15% to 30%, and 
increased in all beta-hemolytic Streptococcus spp. 
Conclusions: An upward trend in resistance exists in the USA for 
clincally important Gram-positive organisms. The global expansion 
of TSN Database will enable such trends to be analyzed for Europe 
and other regions. 
[p8871 In vitro sensitivity of corynebacterium 
diphtheriee to antimicrobial agents 
K.H. Engler, M. Warner, R.C. George. C P H L ,  RISL, London, UK 
Objectives: Epidemic diphtheria has re-emerged in the former 
USSR with over 17 000 cases and 4000 deaths reported to WHO, 
1990-97. Erythromycin and penicillin are still the recommended 
drugs for the antimicrobial treatment and control of this disease. We 
have determined the in vitro sensitivity of 410 isolates of C. diphthe- 
A b s t r a c t s  323 
r i m ,  froni 16 countries of the world, to new and existing antiniicro- 
bial agents. 
Methods: Using an agar ddution method, in vitro activities of two 
new ketolides, HMR 3004 and H M R  3647, were compared with 
those of erythromycin (ERY), clarithromycin (CLA), azithromycin 
(AZ), roxithromycin (ROX), plcnicillin (PEN), ofloxacin (OFL) and 
levofloxacin (LEV) against 410 isolates of C. diphtheriae. The culture 
collection comprised biotype (number toxigenidnumber non-toxi- 
genic): p v i s  (167/109), mitis ('I 12/14), be@fanti (0/5) and intermedius 
(112). Bactericidal activities of HMR3004, HMR3647, ERY, PEN 
and LEV were determined against 4 isolates of C. diphtheriae. 
Results: Results, presented as M I C m  and range of MIC (mg/L) 
were: HMR3004 0.004 (0.002-0.063); H M R  3647 0.008 
(0.0024.125); CLA 0.008 (0.004-0.5); EKY 0.026 (0.016-2); ROX 
0.03 (0.016-2): AZ 0.058 (0.03814); LEV 0.215 (0.12550.25); OFL 
0.43 (0.25-0.5); and PEN 0.43 (0.12S50.5). All strains were fully 
sensitive to PEN, LEV and OFL. Five isolates showed intermediate 
resistance to ERY, these isolates also showed reduced susceptibilities 
to the other iiiacrolides and ketolides. LEV was the most rapidly 
bactericidal agent, followed by H M R  3647, H M R  3004, ERY and 
PEN. 
Conclusions: New ketolide and quinolone antimicrobials may 
have a role to play in the treatnient and control of this re-emerging 
pathogen. 
Infections by Gram-positive bacteria 
(p8881 Difficulties in identifying Streptococcus 
pneumoniae (Pnc) 
T. Kaijalainen, S. Rintamaki, E.  Herva, M. Leinonen. National 
Public Healrli Institute (KTL), Departrnent in Oulu, Finland 
Objectives: To evaluate the urefulness of two gene technological 
methods in the identification of Pnc and compare conventional 
methods to these new methods. 
Methods: We studied 100 alpha-hemolytic streptococcal strains 
sent as possible Pnc to KTL in Oulu (National Reference Unit) for 
confirmation of identification and for serotyping. Conventional 
methods included optochin senr,itivity (four commercial disks), tube 
bile solubility and quellung tests. Nucleic acid (NA) tests were 
commercial AccuProbe and in-house P C R  tests based on the ampli- 
fication of pneumolysin gene fragment. 
Results: The table shows the results obtained by different meth- 
ods in four groups of strains catesorized according to optochin sensi- 
tivity (opt S or R; at least two commercial tests positive for S) and 
capsular quellung reaction (caps+or -) to pneumococcal Omni 
serum. 
Conclusions: In our study. NA methods properly identified 
unequivocal Pnc strains. The two NA methods and conventional 
methods used gave discrepant findings when equivocal strains were 
tested. Further studies are needed to evaluate the exact role of NA 
tests in the identification of pneumococci. 
Lp8891 Evolution of the susceptibility of Streptococcus 
pneumoniae invasive isolates in the last 
decade 
D. Fontanals, I .  Sanfeliu, D. Mariscal, C. Lliniinana, M. Lloret, I. 
Pons. Department of Microbiolpqy, Corporacid Sariitdria Par( %di, 
Sabadell, Barcelona, Spain 
Objectives: To analyze the evolution of the succeptibility patterns 
of Streptococcus pneimoniae (S. pnrumonine) invasive isolatec against 
penicillin (PEN), cefotaxime (CTX) and erythromycin (ERY) in our 
area. 
Materials and methods: A comparative study was made of the 
periods 1989-93 and 1994-98. Susceptibility testing was performed 
on all invasive strainc (blood and sterile fluids) of S .  pneiwroniae 
isolated in Sabadell hospital, using the agar dilution and broth 
microdilution methods according to NCCLS criteria. 
Results: A total of 375 strains of S. pneumoniae were ctudied (173 
from the first period and 202 from the second one). Eighty-nine 
(23.7%) were from children and 286 (76.3%) from adults. The over- 
all percentages of antimicrobial resistance in the first and the second 
period were, respectively: PEN 19.6% and 34.2% (p=0.002); CTX 
9.2% and 9.9% (p=0.83); and ERY 6.3% and 20.8% @<0.001). In 
adults, percentages of antimicrobial resistance were: PEN 15.9%) and 
29.7% @=0.006); C T X  8.7% and 9.4% @=0.82); and ERY 4.3% 
and 14.8% @=0.003). In children, percentages of antimicrobial resis- 
tance were: PEN 34.3% and 46.3% ( ~ ~ 0 . 2 6 ) ;  CTX 11.4% and 11.1%1 
@=0.96); and ERY 14.3% and 37% @=0.02). 
Conclusions: During the study period we detected an important 
increase in resistance of S. pneumoniae to PEN and ERY while C T X  
is similar in both periods. Children's resistance was higher than 
adults' resistance. These data show that antibiotic resistance in pneu- 
mococci is highly prevalent in our area and CTX seems to be the 
elective treatment 
(p890( Characteristics of invasive Streptococcus 
pneumoniae infections in a French area 
C. Fabe, J. Maugein, A. Arininaud du Chatelet, M.C. Bezian, E 
Boineau, J.P. Brochet, D. Cassignard, M.P. Denjean, B.P. Doernian, 
2. EI Harif, I. Fischer, S. Fourniau, J. Jullin, L. Hugard, J.P 
Laffargue, G. Larrouy, B. Dutilh, C. Rongier, R. Sanchez, C. 
Tamarelle. Haut-Leveque Hospital, University o j  Bordeaux, Pessac, 
France 
Objectives and methods: In Aquitaine, a French area, S. prreirmonine 
with reduced sensitivity to penicillin (PDSP) are widespread. The 
objective of this study was to determine the antimicrobial suscepti- 
bility of invasive strains and identify demographic characteristics. 
treatment and outcomes of patients with invasive S. pneumoniac 
infection. During a surveillance study to determine the relative 
prevalence of PDSP in Aquitaine between October 1996 and 
September 1997, 19 laboratories have studied 151 bacteremia and 
meningitis cases. The susceptibility to penicillin was routinely 
screened using the oxacillin 5-pg diffusion test and confirmed by 
MIC determination. 
Results: One hundred and fifty-one pneuniococcal strains have 
been isolated from CSF (u=21) and blood (n=130). Patients 
included 18 children and 133 adults. Patient ages ranged from 1 to 
98 years (52% over 60 years). The most common sources of bac- 
teremia were the lungs (74%). The percentage of PDSP was 48% for 
CSF and 38% for blood. This rate was 39% for community-acquired 
infections and 50% for hospital-acquired episodes. A total of 124 
(82%) patients were cured and 27 (18%) died. Multivariate analysis 
identified two risk factors associated with higher mortality: the age 
